Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy

Our data confirm sustained gains of motor function in early-treated patients and disease stabilisation in patients in the chronic phase under nusinersen treatment.

Authors

Institutions

Publication Details

Journal
Clinical Neurology and Neurosurgery
Published
2025-05-26
DOI
https://doi.org/10.1016/j.clineuro.2025.108983
Citations
4
Primary Topic
Neurogenetic and Muscular Disorders Research
Type
article
Field-Weighted Citation Impact
6.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy

Andrea Klein, Georg Martin Stettner, Paolo Ripellino, Esther Irene Schwarz et al.
4 citations
Clinical Neurology and Neurosurgery
Neurogenetic and Muscular Disorders Research
6.50
article

Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy

Andrea Klein, Georg Martin Stettner, Paolo Ripellino, Esther Irene Schwarz, Cornelia Enzmann, Bettina Schreiner, Olivier Scheidegger, Christoph Neuwirth, Elea Galiart, Leonie Steiner, Bettina Henzi, Philip J. Broser, David Jacquier, Andrea Mathis, Anne Tscherter, Gian Paolo Ramelli
article en
4 citations

Abstract

Our data confirm sustained gains of motor function in early-treated patients and disease stabilisation in patients in the chronic phase under nusinersen treatment.

Clinical Neurology and NeurosurgeryVol. 255
University of Bern (CH), University of Zurich (CH), University of St.Gallen (CH), University Hospital of Bern (CH), Laboratory for Biomedical Neurosciences (CH), Ospedale San Giovanni Bellinzona (CH), University Hospital of Zurich (CH), Institute of Oncology Research (CH), University Children’s Hospital Bern (CH), University Children’s Hospital Basel (CH), University Children's Hospital Zurich (CH), Institute of Social and Preventive Medicine (CH), Università della Svizzera italiana (CH), University of Lausanne (CH)
Pfizer, Biogen, Universität Basel, University of Bern, Stiftung für die Erforschung der Muskelkrankheiten, PTC Therapeutics, Sarepta Therapeutics, Inselspital, Universitätsspital Bern, Centre Hospitalier Universitaire Vaudois, Universitätsspital Zürich
Openalex Percentile: Top 4%
Neurogenetic and Muscular Disorders Research
6.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.